PNC Financial Services Group’s Palisade Bio PALI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$585 Buy
+433
New +$844 ﹤0.01% 5120
2017
Q2
– Hold
0
– -$28K – 4209
2017
Q1
– Hold
0
– – – 3150
2016
Q4
– Hold
0
– – – 3729
2016
Q3
– Hold
0
– – – 3480
2016
Q2
– Hold
0
– – – 3606
2016
Q1
– Hold
0
– – – 3193
2015
Q4
– Hold
0
– – – 2914
2015
Q3
– Hold
0
– – – 2872
2015
Q2
– Hold
0
– – – 2902
2015
Q1
– Hold
0
– – – 3029
2014
Q4
– Hold
0
– – – 2661
2014
Q3
– Hold
0
– – – 3128
2014
Q2
– Hold
0
– – – 2915
2014
Q1
– Hold
0
– – – 3006
2013
Q4
– Hold
0
– – – 3052
2013
Q3
– Hold
0
– – – 3409

Other funds holding PALI

PNC Financial Services Group's PALI Position: Q3 2026 in Review

PNC Financial Services Group opened a new position in Palisade Bio (PALI) in Q3 2026: 433 shares worth $585. The stake represents ﹤0.01% of the portfolio and ranks #5120 among its holdings.

54 funds tracked by Wall St. Rank hold PALI as of Q3 2026.

  • PNC Financial Services Group held 433 shares of Palisade Bio worth $585 as of Q3 2026.
  • Palisade Bio was a new PNC Financial Services Group position in Q3 2026.
  • Palisade Bio made up ﹤0.01% of PNC Financial Services Group's portfolio in Q3 2026, its #5120 holding.
  • 54 funds tracked by Wall St. Rank held Palisade Bio as of Q3 2026.

Based on PNC Financial Services Group's 13F filing for Q3 2026, filed 6 Nov 2026.